January 30, 2025 – As insulin prices in the United States continue to rise, making it increasingly difficult for diabetic patients to afford essential medication, Insulin Outlet is stepping in to offer a cost-effective solution. By providing safe, affordable, and reliable insulin, the company is committed to helping those struggling with high prescription costs.
With reports of patients being forced to ration doses or forgo medication entirely—sometimes with fatal consequences—Insulin Outlet offers a critical lifeline. The Centers for Disease Control and Prevention (CDC) estimated in 2024 that approximately 15.8% of U.S. adults have diabetes.
“It is unacceptable that so many individuals are forced to make impossible choices between their health and financial stability,” said Hank Popeil, Public Relations Manager at Insulin Outlet. “We believe no one should have to compromise their well-being due to inflated medication prices.”
Insulin Outlet provides an alternative by sourcing insulin from reputable international suppliers, ensuring diabetic patients have access to high-quality medications at a fraction of U.S. prices.
“Insulin Outlet plays a crucial role in bridging the gap for Americans struggling with exorbitant medication costs,” said Dr. Ari Magill, a physician with a medical degree from UT Southwestern Medical School and neurology residency training at the University of Arizona. “By offering brand-name insulin at significantly lower prices, they are providing an immediate and practical solution within the healthcare system.”
“Our goal is to demonstrate that quality healthcare doesn’t have to be prohibitively expensive,” Popeil added. “This initiative isn’t just about medication—it’s about transforming lives by removing barriers to essential treatment.”
Operating similarly to a local pharmacy, Insulin Outlet ensures compliance with federal regulations by requiring patients to upload valid prescriptions before completing their purchases.
“We are not just providing insulin; we are offering hope,” said Popeil. “Our team is committed to making sure patients have a safe and affordable alternative.”
The debate over insulin pricing has intensified, with the Federal Trade Commission (FTC) recently filing a lawsuit against major pharmacy benefit managers (PBMs)—CVS Health’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s Optum Rx—accusing them of artificially inflating prices.
“While policy changes are being pursued to address this crisis, one immediate solution is sourcing insulin internationally—Canada being the most accessible option,” said Dr. Baran Erdik, a healthcare consultant with a master’s degree in healthcare administration and policy from Washington State University. “Insulin Outlet stands out as a trusted provider, ensuring U.S. patients can access affordable insulin from Canada without unnecessary hurdles.”
“Our work is just beginning,” Popeil emphasized. “Together, we can drive meaningful change and make life-saving medications accessible to everyone who needs them.”
About Insulin Outlet
Insulin Outlet is dedicated to ensuring that diabetic patients across the United States have access to safe, affordable, and high-quality insulin. By adhering to strict safety protocols and partnering with trusted international suppliers, the company continues to make vital medication more accessible for those in need.
